InvestorsHub Logo
Followers 25
Posts 696
Boards Moderated 0
Alias Born 07/02/2020

Re: maxinvest post# 313554

Tuesday, 07/21/2020 10:37:18 AM

Tuesday, July 21, 2020 10:37:18 AM

Post# of 403134
IMO. We in the US are restricted to pay to play lobbyist and it is hindering the ability for small biotech companies to push to the forefront. Because of this, we may be able to utilize a smaller dose in combination with an approved emergency use drug that has worldwide acceptance and distribution. It would enable our drug to be administered right away until the Q4 study shows Brilacidin both very effective and safe on it's own. It would be of great help to Brilacidin's resume if utilized in combination with good results before the study kicks off.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News